Clinical trial Recruiting at 1 site Observational Ages 18 to 75

Ultrasound-Guided Proximal Superior Cluneal Nerve Block for SCNE

Official title: Clinical Outcomes of Ultrasound-Guided Proximal Superior Cluneal Nerve Block in Patients With Superior Cluneal Nerve Entrapment

Run by Gaziosmanpasa Research and Education Hospital · NCT07712406 · Data updated 2026-11-12

This study tests how well an ultrasound-guided nerve block works for people with superior cluneal nerve entrapment and chronic low back pain.

More Chronic Low-back Pain trials

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexAll
Enrollment40 (estimated)
SponsorGaziosmanpasa Research and Education Hospital
Government
Locations1 site (Gaziosmanpaşa, Istanbul)
StatusRecruiting
StartedMay 15, 2026
Main results expectedNovember 2026
Study endsDecember 2026
Registry record updatedJuly 28, 2026
Trial IDNCT07712406 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-75 with chronic low back or gluteal pain, localized tenderness over the posterior iliac crest, and at least a 50% pain reduction after a diagnostic SCN block.

Probably not a fit

Patients who do not experience pain relief after the diagnostic block or have contraindications to the procedure may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational cohort study will enroll adults with clinically diagnosed superior cluneal nerve entrapment who undergo ultrasound-guided proximal superior cluneal nerve block as part of routine care. Researchers will measure pain intensity, disability, and neuropathic pain features at baseline, 1 month, and 3 months after the procedure using validated outcomes. The primary goal is to see how pain changes after the nerve block; secondary goals include changes in disability and neuropathic pain characteristics. The study aims to provide prospective data on the clinical outcomes of this technique when used in real-world practice. Eligibility includes adults 18-75 with chronic low back/gluteal pain and a positive response to a diagnostic SCN block.

Why it matters

Potential benefit: If successful, patients may experience meaningful reductions in pain and disability after the nerve block.

How similar studies have gone: Ultrasound-guided nerve blocks have shown benefits in similar peripheral nerve entrapment conditions, but prospective data for SCNE are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18-75 years.
* Chronic low back and/or gluteal pain persisting for at least 3 months.
* Localized pain and/or tenderness over the posterior iliac crest.
* At least 50% reduction in pain intensity following diagnostic superior cluneal nerve block.
* Failure of conservative treatment.
* Ability to provide written informed consent.

Exclusion Criteria:

* Previous superior cluneal nerve surgery.
* Active local or systemic infection.
* Bleeding disorders or contraindications to the procedure.
* Allergy to study medications.
* Pregnancy.
* Severe cognitive impairment or inability to complete study assessments.
* Additional interventional pain procedures involving the affected region during follow-up.

Where it's running

  • Gaziosmanpasa Research and Education Hospital
    Gaziosmanpaşa, Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.